Copy

Newsletter 1 - February 2015







General Assembly and Kick-Off COMBACTE MAGNET

Dear colleagues, what a tantalizing meeting we had in Toulouse! More than a 100 participants attended the combined COMBACTE annual meeting and the kick-off meeting of COMBACTE-MAGNET. The number of breakout sessions in which smaller groups discussed the methodological and logistical issues of the clinical studies, demonstrated the enormous amount of activities already being performed and prepared. Read more..









Launch COMBACTE-MAGNET

34 European academic partners and 5 pharmaceutical companies are launching a new project. COMBACTE-MAGNET (Combatting Bacterial Resistance in Europe – Molecules against Gram-Negative Infections) will bring highly innovative studies and activities related to prevention and treatment of infections caused by multi-drug resistant Gram-negative bacteria. Read more..







COMBACTE GCP course

For all members of COMBACTE we have developed an online, interactive, high-quality GCP course, to help member sites in reaching and maintaining full GCP / ICH compliance. It is with great enthusiasm that we invite you to sign-up for this course now. Read more..



Project Coordinator
Dr. Helen Steel
helen.m.steel@gsk.com

Academic Project Coordinator
Prof. Marc Bonten
M.J.M.Bonten@umcutrecht.nl
Academic Clinical Lead
Bruno Francois MD
bruno.francois@chu-limoges.fr

Deputy Project Co-ordinator
Seamus O'Brien
seamus.obrien@astrazeneca.com


Please contact the PMO team with your ideas for the next newsletter.
Click here to send us your thoughts! Looking forward to hearing from you!





Unsubscribe from this newsletter.

This research project receives support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n° 115523, resources of which are composed of financial contribution from the European Union Seventh Framework Programme (FP7/2007-2013) and EFPIA companies in kind contribution.

Email Marketing Powered by Mailchimp